Who gains clinical benefit from using insulin pump therapy? A qualitative study of the perceptions and views of health professionals involved in the Relative Effectiveness of Pumps over MDI and Structured Education (REPOSE) trial
Diabetic Medicine2015Vol. 33(2), pp. 243–251
Citations Over TimeTop 10% of 2015 papers
Julia Lawton, Jackie Kirkham, David Rankin, David White, Daisy Elliott, Alan Jaap, W Henry Smithson, Simon Heller, the REPOSE Group
Abstract
Our findings add to those studies that highlight the difficulties of using patient characteristics and variables to predict clinical success using CSII. To promote equitable access to CSII, attitudinal barriers and prejudicial assumptions amongst staff about who is able to make effective use of CSII may need to be addressed.
Related Papers
- → Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type(2016)47 cited
- → Patient Perception and Satisfaction With Insulin Pump System: Pilot User Experience Survey(2019)19 cited
- → Long-Term Insulin Pump Treatment in Girls with Type 1 Diabetes and Eating Disorders—Is It Feasible?(2010)16 cited
- → No Disadvantage to Insulin Pump Off vs Pump On During Intermittent High-Intensity Exercise in Adults With Type 1 Diabetes(2019)13 cited
- → Treatment of Diabetes — To Pump or Not to Pump(2021)